Delamanid

64 interactions 4 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Amitriptyline Gatifloxacin Ophthalmic Buprenorphine Relugolix Ketoconazole Topical Foscarnet Injection
62 Major 2 Moderate
All (64) Major (62) Moderate (2)

Major

Delamanid Ivabradine Corlanor Increased risk of QT interval prolongation Details Delamanid Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Delamanid Lefamulin Xenleta Increased risk of QT interval prolongation Details Delamanid Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Delamanid Levofloxacin Levaquin Increased risk of QT interval prolongation Details Delamanid Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Delamanid Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Delamanid Mefloquine Lariam® Increased risk of QT interval prolongation Details Delamanid Metronidazole Flagyl An increased risk of QT interval prolongation Details Delamanid Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Delamanid Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Delamanid Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Delamanid Moxifloxacin Avelox Increased risk of QT interval prolongation Details Delamanid Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Delamanid Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Delamanid Octreotide Bynfezia Increased risk of QT interval prolongation Details Delamanid Octreotide Injection Bynfezia Increased risk of QT interval prolongation Details Delamanid Ofloxacin Floxin® Increased risk of QT interval prolongation Details Delamanid Ofloxacin Ophthalmic Ocuflox Increased risk of QT interval prolongation Details Delamanid Ofloxacin Otic Floxin® Otic Increased risk of QT interval prolongation Details Delamanid Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Delamanid Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.